Citation: Uh. Stenman, Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA - Comment, UROLOGY, 53(6), 1999, pp. 1167-1168
Citation: Uh. Stenman, Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy - Editorial comment, J UROL, 162(6), 1999, pp. 2034-2035
Authors:
Hedstrom, J
Grenman, R
Ramsay, H
Finne, P
Lundin, J
Haglund, C
Alfthan, H
Stenman, UH
Citation: J. Hedstrom et al., Concentration of free hCG beta subunit in serum as a prognostic marker forsquamous-cell carcinoma of the oral cavity and oropharynx, INT J CANC, 84(5), 1999, pp. 525-528
Authors:
Hotakainen, K
Lintula, S
Stenman, J
Rintala, E
Lindell, O
Stenman, UH
Citation: K. Hotakainen et al., Detection of messenger RNA for the beta-subunit of chorionic gonadotrophinin urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction, INT J CANC, 84(3), 1999, pp. 304-308
Authors:
Lukkonen, A
Lintula, S
von Boguslawski, K
Carpen, O
Ljungberg, B
Landberg, G
Stenman, UH
Citation: A. Lukkonen et al., Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients, INT J CANC, 83(4), 1999, pp. 486-490
Authors:
Virtanen, A
Gomari, M
Kranse, R
Stenman, UH
Citation: A. Virtanen et al., Estimation of prostate cancer probability by logistic regression: Free andtotal prostate-specific antigen, digital rectal examination, and heredity are significant variables, CLIN CHEM, 45(7), 1999, pp. 987-994
Citation: Uh. Stenman, New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease, CLIN CHEM, 45(6), 1999, pp. 753-754
Authors:
Zhang, WM
Finne, P
Leinonen, J
Vesalainen, S
Nordling, S
Stenman, UH
Citation: Wm. Zhang et al., Measurement of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in serum, CLIN CHEM, 45(6), 1999, pp. 814-821
Citation: Mh. Black et al., Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays, CLIN CHEM, 45(3), 1999, pp. 347-354
Authors:
Hedstrom, J
Haglund, C
Kemppainen, E
Leinimaa, M
Leinonen, J
Stenman, UH
Citation: J. Hedstrom et al., Time-resolved immunofluorometric assay of trypsin-I complexed with alpha(1)-antitrypsin in serum: Increased immunoreactivity in patients with biliarytract cancer, CLIN CHEM, 45(10), 1999, pp. 1768-1773
Authors:
Maattanen, L
Auvinen, A
Stenman, UH
Rannikko, S
Tammela, T
Aro, J
Juusela, H
Hakama, M
Citation: L. Maattanen et al., European randomized study of prostate cancer screening: first-year resultsof the Finnish trial, BR J CANC, 79(7-8), 1999, pp. 1210-1214
Authors:
Hedstrom, J
Svens, E
Kenkimaki, P
Kemppainen, E
Puolakkainen, P
Haapiainen, R
Stenman, UH
Citation: J. Hedstrom et al., Evaluation of a new urinary amylase test strip in the diagnosis of acute pancreatitis, SC J CL INV, 58(8), 1998, pp. 611-616
Authors:
Zhang, WM
Finne, P
Leinonen, J
Vesalainen, S
Nordling, S
Rannikko, S
Stenman, UH
Citation: Wm. Zhang et al., Characterization and immunological determination of the complex between prostate-specific antigen and alpha(2)-macroglobulin, CLIN CHEM, 44(12), 1998, pp. 2471-2479